Antiestrogenic compounds inhibit estrogen-induced expressions of basic fibroblast growth factor and its mRNA in well-differentiated endometrial cancer cells

General Pharmacology

Volumn 28, Issue 2, 1997, Pages 215-219

  Fujimoto, Jiro ^a   Hori, Masashi ^a   Ichigo, Satoshi ^a   Hirose, Reiko ^a   Tamaya, Teruhiko ^a  

^a GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

antiestrogen compounds; basic FGF; endometrial cancer (Ishikawa) cell line; mRNA

Indexed keywords

ANTIESTROGEN; BASIC FIBROBLAST GROWTH FACTOR; DANAZOL; ESTRADIOL; ESTROGEN; GESTAGEN; HYDROCORTISONE; HYDROXYPROGESTERONE; MEDROXYPROGESTERONE ACETATE; MESSENGER RNA; PROGESTERONE; TAMOXIFEN; TETRAHYDROCORTISOL;

ARTICLE; CANCER CELL CULTURE; CELL DIFFERENTIATION; CONTROLLED STUDY; DRUG INHIBITION; ENDOMETRIUM CANCER; GENE EXPRESSION; HUMAN; HUMAN CELL; NEOVASCULARIZATION (PATHOLOGY); PRIORITY JOURNAL; PROTEIN SECRETION;

ADENOCARCINOMA; BLOTTING, SOUTHERN; ENDOMETRIAL NEOPLASMS; ESTRADIOL; ESTROGEN ANTAGONISTS; FEMALE; FIBROBLAST GROWTH FACTOR 2; HUMANS; POLYMERASE CHAIN REACTION; PROGESTERONE; RNA, MESSENGER; STEROIDS; TUMOR CELLS, CULTURED;

EID: 0031033726     PISSN: 03063623     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-3623(96)00188-7     Document Type: Article

References (22)

1. Arcari P., Martinelli R. and Salvatore F. (1984) The complete sequences of a full length cDNA for human liver glyceraldehyde-3-phosphate dehydrogenase: evidence for multiple mRNA species. Nucleic Acids Res. 12, 9179-9189.
2. Bradford M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 315-323.
3. Chomczynski P. and Sacchi N. (1983) Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 33-37.
4. Denekamp, J. (1984) Vascular as a target for tumor therapy. Prog. Appl. Microcirc. 4, 28-38.
5. Enenstein J., Waleh N. S. and Kramer R. H. (1992) Basic FGF and TGF-β differentially modulate integrin expression of human microvascular endothelial cells. Exp. Cell Res. 203, 499-503.
6. Folkman J. (1985) Tumor angiogenesis. Adv. Cancer Res. 43, 175-203.
7. Folkman J. and Haudenschild C. (1980) Angiogenesis in vitro. Nature 288, 551-556.
8. Folkman J. and Ingber D. E. (1987) Angiostatic steroids. Ann. Surg. 206, 374-383.
9. Fujimoto J., Hori M., Ichigo S., Morishita S. and Tamaya T. (1995) Estrogen activates invasiveness of endometrial cancer cells to the interstitium. Invasion Metastasis. 15, 135-143.
10. Kurokawa T., Sasada R., Iwane M. and Igarashi K. (1987) Cloning and expression of cDNA encoding human basic fibroblast growth factor. FEBS Lett. 213, 189-194.
11. Kandel J., Bossy-Wetzel E., Radvanyi F., Klagsburn M., Folkman J. and Hanahan D. (1991) Neovascularization is associated with a switch to the export of b-FGF in the multistep development of fibrosarcoma. Cell 66, 1095-1104.
12. Macchiarini P., Fontanini G., Hardin M. J., Squartini F. and Angeletti G. A. (1992) Relation of neovascularization to metastasis of non-small-cell lung cancer. Lancet 340, 145-146.
13. Mignatti P., Mazzieri R. and Rifkin D. B. (1991) Expression of the urokinase receptor in vascular endothelial cells is stimulated by basic fibroblast growth factor. J. Cell Biol 113, 1193-1201.
14. Muthukrishnan L., Warder E. and McNeil P. L. (1991) Basic fibroblast growth factor is efficiently released from a cytolsolic storage site through plasma membrane disruptions of endothelial cells. J. Cell Physiol. 148, 1-16.
15. Nakamoto T., Chang C. and Li A. (1992) Basic fibroblast growth factor in human prostatic cancer cells. Cancer Res. 52, 571-577.
16. Nishida M., Kasahara K., Kaneko M. and Iwasaki H. (1985) Establishment of a new human endometrial adenocarcinoma cell line, Ishikawa cells, containing estrogen and progesterone receptors. Acta Obstet. Gynecol. Jpn. 37, 1103-1110.
17. Randall L. L. and Hardy S. J. S. (1988) Unity in function in the absence of consensus in sequence: role of leader peptides in export. Science 243, 1156-1159.
18. Srivastava A., Laidler P., Davies R. P., Horgan K. and Hughes L. (1988) The prognostic significance of tumor vascularity in intermediate-thickness (0.76-0.4 mm thick) skin melanoma. Am J. Pathol. 133, 419-423.
19. Szego C. M. and Pitras R. J. (1981) Membrane recognition and effector sites in steroid hormone action. In: Biochemical Actions of Hormones. (Edited by G. Litwack), Vol. III, pp. 308-463. Academic Press, New York.
20. Wakui S., Furusato M., Itoh T., et al. (1992) Tumor angiogenesis in prostatic carcinoma with and without bone marrow matastasis: a morphometric study. J. Pathol. 168, 257-262.
21. Weider N., Carroll P. R., Flax J., Blumenfeld W. and Folkman J. (1993) Tumor angiogenesis correlates with metstasis in invasive prostate carcinoma. Am. J. Pathol. 143, 401-409.
22. Weidner N., Semple J. P., Welch W. R. and Folkman J. (1991) Tumor angiogenesis and metastasis - Correlation in invasive breast carcinoma. N. Engl. J. Med. 324, 1-7.